The double transgenic mouse model (APPswe/PS1dE9) of Alzheimer\u2019s disease (AD) has been widely used in experimental studies. \u3b2-Amyloid (A\u3b2) peptide is excessively produced in AD mouse brain, which affects synaptic function and the development of central nervous system. However, little has been reported on characterization of this model. The present study aimed to characterize this mouse AD model and its wild-type counterparts by biochemical and functional approaches.Peer reviewed: YesNRC publication: Ye
Tauopathies encompass several of the most prevalent neurodegenerative diseases that consistently pro...
Alzheimer disease (AD) is the leading cause of dementia among elderly. Currently, no effective treat...
International audienceBackground: Alzheimer's disease (AD) brain dysfunctions are not exclusively re...
ABSTR ACT: Transgenic (Tg) mouse models of Alzheimer’s disease (AD) have been extensively used to st...
BACKGROUND: Numerous mouse models of Alzheimer's disease (AD) are available, but all suffer from cer...
Transgenic (Tg) mouse models of Alzheimer\u27s disease (AD) have been extensively used to study the ...
Alzheimer's disease (AD) constitutes the most prominent form of dementia among elderly individuals w...
The pathophysiology of chronic neurodegenerative diseases, as Alzheimer's diseases, has remained ina...
Transgenic mouse models are powerful tools in exploring the mechanisms of AD. Most current transgeni...
Abstract Alzheimer’s disease (AD) is behaviorally identified by progressive memory impairment and pa...
The appropriateness of three animal models in mimicking pathophysiology and symptoms of Alzheimer's ...
Alzheimer’s disease (AD) is a debilitating neurodegenerative disorder characterized by progressive m...
The ability to investigate therapeutic interventions in animal models of neurodegenerative diseases ...
Animal models of disease are valuable resources for investigating pathogenic mechanisms and potentia...
We describe the thorough characterisation of a new transgenic mouse line overexpressing the 695-amin...
Tauopathies encompass several of the most prevalent neurodegenerative diseases that consistently pro...
Alzheimer disease (AD) is the leading cause of dementia among elderly. Currently, no effective treat...
International audienceBackground: Alzheimer's disease (AD) brain dysfunctions are not exclusively re...
ABSTR ACT: Transgenic (Tg) mouse models of Alzheimer’s disease (AD) have been extensively used to st...
BACKGROUND: Numerous mouse models of Alzheimer's disease (AD) are available, but all suffer from cer...
Transgenic (Tg) mouse models of Alzheimer\u27s disease (AD) have been extensively used to study the ...
Alzheimer's disease (AD) constitutes the most prominent form of dementia among elderly individuals w...
The pathophysiology of chronic neurodegenerative diseases, as Alzheimer's diseases, has remained ina...
Transgenic mouse models are powerful tools in exploring the mechanisms of AD. Most current transgeni...
Abstract Alzheimer’s disease (AD) is behaviorally identified by progressive memory impairment and pa...
The appropriateness of three animal models in mimicking pathophysiology and symptoms of Alzheimer's ...
Alzheimer’s disease (AD) is a debilitating neurodegenerative disorder characterized by progressive m...
The ability to investigate therapeutic interventions in animal models of neurodegenerative diseases ...
Animal models of disease are valuable resources for investigating pathogenic mechanisms and potentia...
We describe the thorough characterisation of a new transgenic mouse line overexpressing the 695-amin...
Tauopathies encompass several of the most prevalent neurodegenerative diseases that consistently pro...
Alzheimer disease (AD) is the leading cause of dementia among elderly. Currently, no effective treat...
International audienceBackground: Alzheimer's disease (AD) brain dysfunctions are not exclusively re...